Cargando…
RhoC: a fascinating journey from a cytoskeletal organizer to a Cancer stem cell therapeutic target
Tumor heterogeneity results in differential response to therapy due to the existence of plastic tumor cells, called cancer stem cells (CSCs), which exhibit the property of resistance to therapy, invasion and metastasis. These cells have a distinct, signaling network active at every stage of progress...
Autores principales: | Thomas, Pavana, Pranatharthi, Annapurna, Ross, Cecil, Srivastava, Sweta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651989/ https://www.ncbi.nlm.nih.gov/pubmed/31340863 http://dx.doi.org/10.1186/s13046-019-1327-4 |
Ejemplares similares
-
RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer
por: Pranatharthi, Annapurna, et al.
Publicado: (2019) -
Cancer Stem Cells and Radioresistance: Rho/ROCK Pathway Plea Attention
por: Pranatharthi, Annapurna, et al.
Publicado: (2016) -
A RhoC Biosensor Reveals Differences in the Activation Kinetics of RhoA and RhoC in Migrating Cells
por: Zawistowski, Jon S., et al.
Publicado: (2013) -
Role of RhoC in cancer cell migration
por: Lou, Yingyue, et al.
Publicado: (2021) -
RhoA, RhoB and RhoC differentially regulate endothelial barrier function
por: Pronk, Manon C. A., et al.
Publicado: (2017)